Home › Funds › Alyeska Investment Group, L.P. › APH

Alyeska Investment Group, L.P. position in APH

AMPHENOL CORP · Technology

Alyeska Investment Group, L.P. reported holding 5,296,929 shares of APH (AMPHENOL CORP) in its Q3 2026 13F filing — a position valued at US$446.5M, representing 1.17% of its reported portfolio and ranking #9 among its reported holdings. Alyeska Investment Group, L.P. has disclosed APH holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)5.30M sh
Reported value held$446.53M
Portfolio Weight1.17%
First reportedQ3 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Alyeska Investment Group, L.P.'s APH position evolved

Alyeska Investment Group, L.P. first disclosed a stake in APH in Q3 2024 at 2,044,794 shares (US$133.2M). The position peaked in Q3 2026 at 5,296,929 shares, worth US$446.5M. Across 7 filings, Alyeska Investment Group, L.P. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,296,929 shares valued at US$446.5M — an increase of 2,978,751 shares quarter over quarter.. Notable position changes include a 6734% increase in Q2 2025 (shares rose 25% over the following quarter), a 53% increase in Q1 2026 (shares rose 40% over the following quarter), a 128% increase in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.04M $133.24M New
Q1 2025 6.04K $396.16K New
Q2 2025 412.79K $40.76M Add
Q4 2025 1.85M $250.29M New
Q1 2026 2.84M $358.44M Add
Q2 2026 2.32M $408.74M Reduce
Q3 2026 5.30M $446.53M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APH and 13F data

APH (AMPHENOL CORP) is a Technology company. 45 other funds we track also report a position in APH — the largest reported positions include Fidelity Management & Research (FMR) (US$10.58B), Capital International Investors (US$7.30B), PRICE T ROWE ASSOCIATES INC /MD/ (US$6.08B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APH

All APH fund holders →

FAQ

How long has Alyeska Investment Group, L.P. held APH?

Alyeska Investment Group, L.P. has disclosed APH holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

What is Alyeska Investment Group, L.P.'s current position in APH?

As of Q3 2026, Alyeska Investment Group, L.P. holds 5.30M shares of APH (AMPHENOL CORP), valued at $446.53M, representing 1.17% of its reported portfolio and ranking #9.

Has Alyeska Investment Group, L.P. been buying or selling APH?

In the latest 13F filing (Q3 2026), Alyeska Investment Group, L.P. increased its position in APH. The position peaked in Q3 2026 at 5.30M shares.

Which other funds hold APH?

Other major institutional holders of APH include Fidelity Management & Research (FMR), Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.